ArticleFrontiers in pharmacology2020

Combined Treatment With 2-(2-Benzofu-Ranyl)-2-Imidazoline and Recombinant Tissue Plasminogen Activator Protects Blood-Brain Barrier Integrity in a Rat Model of Embolic Middle Cerebral Artery Occlusion.

Linlei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.